SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-23-026081
Filing Date
2023-10-18
Accepted
2023-10-18 17:43:35
Documents
1
Period of Report
2023-10-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 9498
  Complete submission text file 0001127602-23-026081.txt   10815
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address
Machiels Alec (Reporting) CIK: 0001496687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 231332955